NCT06196008 Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
| NCT ID | NCT06196008 |
| Status | Recruiting |
| Phase | — |
| Sponsor | City of Hope Medical Center |
| Condition | Lung Carcinoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 382 participants |
| Start Date | 2023-12-05 |
| Primary Completion | 2028-05-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 382 participants in total. It began in 2023-12-05 with a primary completion date of 2028-05-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial compares telephone-based physical activity coaching to self monitored physical activity for improving physical function in older adults who are undergoing surgery for lung cancer and their caregivers. Lung cancer surgery in older adults is associated with functional declines and unique challenges. Performing physical activity around the time of surgery has been shown to improve functional outcomes in patients and exercise programs delivered via telehealth may improve access and convenience for patients and minimize participant burden. Telephone-based physical activity coaching may improve physical functioning for older adults with lung cancer who are undergoing surgery.
Eligibility Criteria
Inclusion Criteria: * PATIENT: Documented informed consent of the participant and/or legally authorized representative * PATIENT: Agreement to allow the use of preoperative chest CT scan for exploratory analysis, if available * PATIENT: Agreement to wear pedometer during study duration * If unwilling, exceptions may be granted with study primary investigator (PI) approval * PATIENT: Age \>= 65 years * PATIENT: Ability to read and understand English or Spanish and willingness to complete participant-reported outcomes and assessments * PATIENT: Diagnosis of lung cancer or presumed lung cancer (as determined by surgeons) in patient * PATIENT: Scheduled to undergo lung surgery for lung cancer or suspected lung cancer with curative intent (neoadjuvant therapy allowed) * PATIENT: Adults lacking capacity to consent in the opinion of the attending surgeon will not be enrolled * FCG: Documented informed consent of the participant and/or legally authorized representative * FCG: Age \>= 18 * FCG: Ability to read and understand English or Spanish and willingness to complete participant-reported outcomes and assessments * FCG: Adults lacking capacity to consent in the opinion of the attending surgeon will not be enrolled Exclusion Criteria: * PATIENT: Lung surgery is scheduled in less than 14 calendar days from the time of registration * PATIENT: Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including exercise program and compliance issues related to feasibility/logistics) * FCG: Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including exercise program and compliance issues related to feasibility/logistics)
Contact & Investigator
Dan Raz, MD
PRINCIPAL INVESTIGATOR
City of Hope Medical Center
Frequently Asked Questions
Who can join the NCT06196008 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06196008 currently recruiting?
Yes, NCT06196008 is actively recruiting participants. Contact the research team at draz@coh.org for enrollment information.
Where is the NCT06196008 trial being conducted?
This trial is being conducted at Davis, United States, Duarte, United States, Irvine, United States, Stanford, United States and 11 additional locations.
Who is sponsoring the NCT06196008 clinical trial?
NCT06196008 is sponsored by City of Hope Medical Center. The principal investigator is Dan Raz, MD at City of Hope Medical Center. The trial plans to enroll 382 participants.